<DOC>
	<DOC>NCT00863772</DOC>
	<brief_summary>Tanezumab reduces pain of osteoarthritis without affecting how nerve impulses are transmitted in sensory nerves.</brief_summary>
	<brief_title>Tanezumab and Nerve Function In Arthritis Patients</brief_title>
	<detailed_description>This study was terminated on 16 Nov 2010 following a US FDA clinical hold for tanezumab osteoarthritis clinical studies which halted dosing and enrollment of patients on 23 June 2010 for potential safety issues.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>BMI less or equal to 39 kg/m2 Osteoarthritis (arthritis) of the knee or hip with pain score that qualifies Willing to comply with study visit schedule and study requirements, including, for women of childbearing potential or male patients with female partners of childbearing potential, the use of 2 forms of birth control, one of which is a barrier method. Patients must consent in writing to participate in the study. Untreated, uncontrolled diseases, Unwilling or unable to discontinue the use of prohibited medications, including other pain medications, during the screening period and during the study, Significant cardiac disease within the past 6 months Significant neurological disease (e.g. peripheral neuropathy, multiple sclerosis, stroke) or signs of neuropathy at screening Known bleeding disorder or anticoagulation therapy Planned surgery during the study period History of alcoholism or drug abuse in the past 2 years Unable to use acetaminophen Use of a biologic (including live vaccines, with the exception of Flumist) within the past 3 months Allergic reaction to a biologic or an antibody in the past Disqualifying laboratory values, including Hepatitis B or C, HIV or drug test Cancer in the past 5 years. Basal cell or squamous cell carcinoma are okay. Medical condition that may interfere with study endpoints or safety of the subject as determined by the investigator.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>